Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,624 | -119,763 | -82,508 | -105,584 | -93,961 |
| Depreciation Amortization | 992 | 2,465 | 4,032 | 4,697 | 2,932 |
| Accounts payable and accrued liabilities | 2,691 | -2,792 | -4,927 | 8,821 | -8,044 |
| Other Working Capital | 2,078 | -1,808 | -9,286 | -1,018 | 4,796 |
| Other Operating Activity | 15,558 | 66,725 | 14,596 | 2,356 | 16,068 |
| Operating Cash Flow | $-84,305 | $-55,173 | $-78,093 | $-90,728 | $-78,209 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 13,872 | 13,170 | 12,433 | -19,469 |
| Investing Cash Flow | $N/A | $13,872 | $13,170 | $12,433 | $-19,469 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114,116 | 74,854 | 27,860 | 75,001 | 135,919 |
| Other Financing Activity | -311 | -312 | -168 | -284 | 375 |
| Financing Cash Flow | $113,805 | $74,542 | $27,692 | $74,717 | $136,294 |
| Beginning Cash Position | 49,898 | 16,657 | 53,888 | 57,466 | 18,850 |
| End Cash Position | 79,398 | 49,898 | 16,657 | 53,888 | 57,466 |
| Net Cash Flow | $29,500 | $33,241 | $-37,231 | $-3,578 | $38,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,305 | -55,173 | -78,093 | -90,728 | -78,209 |
| Free Cash Flow | -84,305 | -55,173 | -78,093 | -90,728 | -78,209 |